Anti-LRRK2 antibody [MJFF4 (c81-8)] - Low endotoxin, Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal LRRK2 antibody. Carrier free. Suitable for WB, IHC-P, IP and reacts with Human, Mouse samples. Cited in 1 publication.
View Alternative Names
PARK8, LRRK2, Leucine-rich repeat serine/threonine-protein kinase 2, Dardarin
- WB
Lab
Western blot - Anti-LRRK2 antibody [MJFF4 (c81-8)] - Low endotoxin, Azide free (AB205335)
This data was developed using the same antibody clone in a different buffer formulation (ab133476).
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : LRRK2 knockout HAP1 cell lysate (20 μg)
Lane 3 : MEF cell lysate (20 μg)
Lane 4 : LRRK2 knockout MEF cell lysate (20 μg)
Lane 5 : A549 cell lysate (20ug)
Lane 6 : LRRK2 knockout A549 cell lysate (20 μg)
Lanes 1 - 6 : Merged signal (red and green). Green – ab133476 observed at 238 kDa. Red - loading control, ab130007, observed at 124 kDa.
ab133476 was shown to specifically react with LRRK2 in wild type A549, MEF and HAP1 cells along with additional cross-reactive bands. No band was observed when LRRK2 knockout samples were used. Wild-type and LRRK2 knockout samples were subjected to SDS-PAGE. ab133476 and ab130007 (loading control to Vinculin) were diluted at 1/500 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
Wild-type and LRRK2 knockout MEF and A549 cells were provide as a generous gift from Professor Dario Alessi, MRC Protein Phosphorylation and Ubiquitination Unit (University of Dundee).
All lanes:
Western blot - Anti-LRRK2 antibody [MJFF4 (c81-8)] - Low endotoxin, Azide free (ab205335)
Predicted band size: 286 kDa
false
Related conjugates and formulations (2)
-
Anti-LRRK2 antibody [MJFF4 (c81-8)] - BSA and Azide free
-
Anti-LRRK2 antibody [MJFF4 (c81-8)]
Reactivity data
Product details
ab205335 is the carrier-free version of ab133476.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
What does low endotoxin mean?
Our low endotoxin, azide-free formats have low endotoxin level (1 EU/mg, determined by the TAL assay) and are free from azide, to achieve consistent experimental results in functional assays.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LRRK2 interacts with cellular mechanisms by regulating cytoskeletal dynamics autophagy and vesicle trafficking. It is a part of a larger complex that includes other proteins involved in these processes. The kinase activity of LRRK2 plays an essential part in maintaining neuronal health and function. It influences the process of autophagy which is a way cells clean themselves by removing damaged components and recycling them.
Pathways
The action of LRRK2 is central to the mitogen-activated protein kinase (MAPK) and the mammalian target of rapamycin (mTOR) pathways. In these pathways LRRK2 interacts with other proteins such as mTOR and RPS6KB1. It modulates cellular processes like growth proliferation and response to stressors. Its kinase activity affects the phosphorylation state of targets within the pathways hence influencing biological outcomes like survival and apoptosis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nanoscale research letters 14:228 PubMed31289961
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com